128 related articles for article (PubMed ID: 35772636)
1. Successful use of dupilumab to treat eczema in a child with X-linked agammaglobulinemia.
Atwal S; Ong PY
Ann Allergy Asthma Immunol; 2022 Sep; 129(3):384-386. PubMed ID: 35772636
[No Abstract] [Full Text] [Related]
2. Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia.
Fujishima C; Munemoto S; Hioki C; Sasaki H; Yoshida H; Yamamoto T; Kudo H
Eur J Dermatol; 2022 May; 32(3):416-417. PubMed ID: 36065552
[No Abstract] [Full Text] [Related]
3. Successful treatment of atopic dermatitis with dupilumab in the setting of X-linked agammaglobulinemia.
Fan YH; Lin TL; Sun HL; Pan HH; Ku MS; Lue KH
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):3032-3034.e1. PubMed ID: 35961615
[No Abstract] [Full Text] [Related]
4. Vedolizumab is safe and effective in the treatment of X-linked agammaglobulinemia-associated inflammatory bowel disease.
King JR; Grover Z; Irani N; McLean-Tooke A
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):1006-1007. PubMed ID: 33259974
[No Abstract] [Full Text] [Related]
5. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
Çekiç Ş; Özgür T; Karalı Y; Özkan T; Kılıç SŞ
Turk J Pediatr; 2019; 61(6):937-940. PubMed ID: 32134589
[TBL] [Abstract][Full Text] [Related]
6. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.
Loman L; Diercks GFH; Schuttelaar MLA
Contact Dermatitis; 2021 Feb; 84(2):124-127. PubMed ID: 32864776
[No Abstract] [Full Text] [Related]
7. X-Linked agammaglobulinemia in a child with Klinefelter's syndrome.
Cochino AV; Janda A; Ravcukova B; Plaiasu V; Ochiana D; Gherghina I; Freiberger T
J Clin Immunol; 2014 Feb; 34(2):142-5. PubMed ID: 24477949
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hand eczema with dupilumab-A retrospective follow-up study.
Olesen CM; Yüksel YT; Zachariae C; Lund TT; Agner T; Petersen TS; Thyssen JP
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e557-e559. PubMed ID: 36463422
[No Abstract] [Full Text] [Related]
9. Dupilumab treatment of eczema in a child with STAT3 hyper-immunoglobulin E syndrome.
Wang HJ; Yang TT; Lan CE
J Eur Acad Dermatol Venereol; 2022 May; 36(5):e367-e369. PubMed ID: 34927771
[No Abstract] [Full Text] [Related]
10. Dupilumab treatment of nummular dermatitis: A retrospective cohort study.
Choi S; Zhu GA; Lewis MA; Honari G; Chiou AS; Ko J; Chen JK
J Am Acad Dermatol; 2020 May; 82(5):1252-1255. PubMed ID: 31923445
[No Abstract] [Full Text] [Related]
11. Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
Maher MC; Hall EM; Horii KA
Pediatr Dermatol; 2021 Sep; 38(5):1370-1371. PubMed ID: 34272772
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of recalcitrant dyshidrotic eczema with dupilumab in a child.
Weins AB; Biedermann T; Eyerich K; Moeckel S; Schnopp C
J Dtsch Dermatol Ges; 2019 Nov; 17(11):1165-1167. PubMed ID: 31612565
[No Abstract] [Full Text] [Related]
13. Iris atrophy in a patient with X-linked agammaglobulinemia.
Reisli I; Artac H; van der Burg M; Ozturk BT
Can J Ophthalmol; 2007 Dec; 42(6):882-3. PubMed ID: 18059520
[No Abstract] [Full Text] [Related]
14. Eczema and X-linked agammaglobulinaemia.
Hunter HL; McKenna KE; Edgar JD
Clin Exp Dermatol; 2008 Mar; 33(2):148-50. PubMed ID: 18076688
[TBL] [Abstract][Full Text] [Related]
15. A child with X-linked agammaglobulinemia and Kawasaki disease: an unusual association.
Sharma D; Guleria S; Suri D; Rawat A; Garg R; Singh S
Rheumatol Int; 2017 Aug; 37(8):1401-1403. PubMed ID: 28365793
[TBL] [Abstract][Full Text] [Related]
16. Promising results for treatment of severe chronic hand eczema with dupilumab.
Brans R
Br J Dermatol; 2023 Sep; 189(4):360-361. PubMed ID: 37337439
[No Abstract] [Full Text] [Related]
17. A review of dupilumab in the treatment of atopic diseases.
Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
[TBL] [Abstract][Full Text] [Related]
18. Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.
Turvey SE; Leo SH; Boos A; Deans GD; Prendiville J; Crawford RI; Senger C; Conley ME; Tilley P; Junker A; Janz L; Azana R; Hoang L; Morton TL
J Clin Immunol; 2012 Dec; 32(6):1404-8. PubMed ID: 22843217
[TBL] [Abstract][Full Text] [Related]
19. The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging.
Shahriari N; Strober B; Shahriari M
J Am Acad Dermatol; 2020 Nov; 83(5):1533-1535. PubMed ID: 32679275
[No Abstract] [Full Text] [Related]
20. Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease.
Tuzankina I; Kobeleva Y; Kiseleva N; Bolkov M; Reuter G; Maródi L
Allergy; 2011 Dec; 66(12):1617-8. PubMed ID: 21951217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
